News of the WeekLow-Income Countries

A Boost for Vaccine Development

See allHide authors and affiliations

Science  18 Sep 2009:
Vol. 325, Issue 5947, pp. 1489
DOI: 10.1126/science.325_1489a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

This week, Merck and the U.K. biomedical charity Wellcome Trust established a nonprofit vaccine development institute to be based in India. The $145 million private-public partnership will focus on creating vaccines for low-income countries, with an emphasis on making existing vaccines more affordable and easily distributed and on combating unmet disease needs, such as a vaccine for group A streptococci.